Stg Pharmagenerics Private Limited

Pharmaceutical trading company based in Mumbai, established in 2017.

2017 | Mumbai, Maharashtra (India) | Active
Last Updated:

Stg Pharmagenerics Profile

Key Indicators

  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 5.00 M
  • Company Age 8 Year, 17 Days
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 11.00 Cr
  • Revenue Growth 207.01%
  • Profit Growth -2749.25%
  • Ebitda -569.38%
  • Net Worth -280.86%
  • Total Assets -56.18%

About Stg Pharmagenerics

Stg Pharmagenerics Private Limited (SPPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 15 February 2017 (Eight years 17 days old ). Its registered office is in Mumbai, Maharashtra, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 5.00 M.

The company currently has active open charges totaling ₹11.00 Cr.

Tarun Gupta and Rajesh Gupta serve as directors at the Company.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    pkpharma.com

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U51909MH2017FTC291263

  • Company No.

    291263

  • Company Classification

    Private Limited Foreign Company Incorporated In India

  • Incorporation Date

    15 Feb 2017

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Pharma

Who are the key members and board of directors at Stg Pharmagenerics?

Board Members (2)

NameDesignationAppointment DateStatus
Tarun Gupta Country flag representing Hk Director 15-Feb-2017Current
Rajesh Gupta Country flag representing In Whole-Time Director 15-Feb-2017Current

Financial Performance of Stg Pharmagenerics.

Stg Pharmagenerics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 207.01% increase. The company also saw a substantial fall in profitability, with a 2749.25% decrease in profit. The company's net worth observed a substantial decline by a decrease of 280.86%.

Stg Pharmagenerics revenue growth over time
Stg Pharmagenerics profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
207.01%
Revenue from Operations
206.93%
Total Assets
-56.18%
Profit or Loss
-2749.25%
Net Worth
-280.86%
EBITDA
-569.38%

What is the Ownership and Shareholding Structure of Stg Pharmagenerics?

In 2021, Stg Pharmagenerics had a promoter holding of 90.00% and a public holding of 10.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹11.00 Cr

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Axis Bank Limited : 11.00 Cr

Latest Charge Details

DateLenderAmountStatus
27 Jun 2022Axis Bank Limited₹11.00 CrOpen

How Many Employees Work at Stg Pharmagenerics?

Unlock and access historical data on people associated with Stg Pharmagenerics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Stg Pharmagenerics Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Stg Pharmagenerics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stg Pharmagenerics's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Stg Pharmagenerics

Recent activity within the organization

  • Annual General Meeting

    Stg Pharmagenerics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Stg Pharmagenerics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.

  • Charges

    A charge with Axis Bank Limited of Rs. 11.00 Cr registered on 27 Jun 2022 with Charge ID 100633075 was modified on 20 Dec 2023.

  • Charges

    A charge with Axis Bank Limited amounted to Rs. 11.00 Cr with Charge ID 100633075 was registered on 27 Jun 2022.

  • Director Appointment

    Tarun Gupta was appointed as a Director was appointed as a Director on 15 Feb 2017 & has been associated with this company since 8 years 17 days .

  • Director Appointment

    Rajesh Madanlal Gupta was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 15 Feb 2017 & has been associated with this company since 8 years 17 days .

Frequently asked questions

  • What is the Incorporation or founding date of Stg Pharmagenerics Private Limited?

    Stg Pharmagenerics Private Limited was incorporated on 15 Feb 2017.

  • What is authorized share capital and paid-up capital of Stg Pharmagenerics Private Limited?

    The authorized share capital of Stg Pharmagenerics Private Limited is ₹ 2.00 Cr and paid-up capital is ₹ 5.00 M.

  • Who are the current board members & directors of Stg Pharmagenerics Private Limited?

    Currently 2 directors are associated with Stg Pharmagenerics Private Limited.

    • Tarun Gupta
    • Rajesh Madanlal Gupta

  • What is the registered address of Stg Pharmagenerics Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Stg Pharmagenerics Private Limited is 604B Sai Samarth Business Park Near Wasan Motors Deonar Govandi (E), India, Mumbai, Maharashtra, 400088.

  • What is the corporate identification number (CIN) and company number of Stg Pharmagenerics Private Limited?

    The corporate identification number (CIN) of Stg Pharmagenerics Private Limited is U51909MH2017FTC291263 and the company number is 291263 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Stg Pharmagenerics Private Limited?

    The Official website of Stg Pharmagenerics Private Limited is https://www.pkpharma.com

  • What has been the recent revenue trend for Stg Pharmagenerics Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Stg Pharmagenerics Private Limited has risen by 207.01%.

  • What change has been observed in the net worth of Stg Pharmagenerics Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Stg Pharmagenerics Private Limited has experienced an downturn of -280.86%.

  • What are the total open charges for Stg Pharmagenerics Private Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Stg Pharmagenerics Private Limited amount to ₹ 11.00 Cr.

  • When was the last Balance Sheet of Stg Pharmagenerics Private Limited filed with the ROC?

    The most recent Balance Sheet for Stg Pharmagenerics Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development